Ascendis Pharma (ASND) Commences $100M Public Offering of ADSs
Tweet Send to a Friend
Ascendis Pharma A/S (Nasdaq: ASND), a clinical stage biopharmaceutical company, today announced that it has commenced an underwritten public offering ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE